Tvardi Therapeutics Patents – Insights & Stats (Updated 2023)

Tvardi Therapeutics has a total of 51 patents globally, out of which 9 have been granted. Of these 51 patents, more than 96% patents are active. The United States of America is where Tvardi Therapeutics has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Tvardi Therapeutics.

Tvardi Therapeutics was founded in 2017. Tvardi Therapeutics is a privately held biotechnology company in the clinical stage of operation. The company creates and markets medications to treat fibrotic disorders, various malignancies, and chronic inflammation.

Do read about some of the most popular patents of Tvardi Therapeutics which have been covered by us in this article and also you can find Tvardi Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Tvardi Therapeutics patent portfolio.

How many patents does Tvardi Therapeutics have?

Tvardi Therapeutics has a total of 51 patents globally. These patents belong to 9 unique patent families. Out of 51 patents, 49 patents are active.

How Many Patents did Tvardi Therapeutics File Every Year?

Tvardi Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantTvardi Therapeutics Applications FiledTvardi Therapeutics Patents Granted
202341
202265
2021143
202010
201917

How many Tvardi Therapeutics patents are Alive/Dead?

Worldwide Patents

Tvardi Therapeutics Patent Portfolio

How Many Patents did Tvardi Therapeutics File in Different Countries?

Tvardi Therapeutics Worldwide Patent Filing

Countries in which Tvardi Therapeutics Filed Patents

CountryPatent
United States Of America6
Hong Kong (S.A.R.)4
Europe4
Pakistan3
Canada3
Singapore2
Australia2
Mexico2
Brazil2
India2
China1
Poland1
Philippines1
Indonesia1
Spain1
Israel1
Hungary1
Argentina1
Austria1
Italy1
Portugal1
Japan1
Taiwan1
Denmark1
Uruguay1
Norway1
New Zealand1

Where are Research Centers of Tvardi Therapeutics Patents Located?

R&D Centres of Tvardi Therapeutics

What Percentage of Tvardi Therapeutics US Patent Applications Were Granted?

Tvardi Therapeutics (Excluding its subsidiaries) has filed 5 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 100%.

Below are the key stats of Tvardi Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Tvardi Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Goodwin Procter Llp4100%
Norton Rose Fulbright Us Llp10%

What are Tvardi Therapeutics key innovation segments?

What Technologies are Covered by Tvardi Therapeutics?

The chart below distributes patents filed by Tvardi Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Tvardi Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Tvardi Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Tvardi Therapeutics?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.